Figure 8. The percentage of 0.1% trans-resveratrol in two formulations following exposure to UVR in the absence and presence of EHMC at 4%.

Formulators who want their trans-resveratrol products to deliver biological benefits should include a proven photostabilizer to preserve the structural integrity of trans-resveratrol (see Figure 8).